Cardiac Science CORP

Q: Sep 30 2010

Q: Jun 30 2010

Q: Mar 31 2010

FY: Dec 31 2009

Q: Sep 30 2009

Q: Jun 30 2009

Q: Mar 31 2009

FY: Dec 31 2008

Q: Sep 30 2008

Q: Sep 30 2008

Q: Jun 30 2008

Q: Mar 31 2008

FY: Dec 31 2007

Q: Sep 30 2007

Q: Jun 30 2007

Q: Mar 31 2007

FY: Dec 31 2006

Q: Sep 30 2006

Q: Jun 30 2006

Q: Mar 31 2006

Current report pursuant to Section 13 or 15(d)

Entry into a Material Definitive Agreement

2.02,9.01

1.01,9.01

1.01,8.01,9.01

2.02,9.01

1.01,2.03,8.01,9.01

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Submission of Matters to a Vote of Security Holders

5.02

Entry into a Material Definitive Agreement

2.02,9.01

2.02,9.01

Other Events

Results of Operations and Financial Condition

5.02

Results of Operations and Financial Condition

5.02,9.01

5.02

5.02

Notice of Effectiveness

Certification of termination of registration of a class of securities (Section 12(g))

Post-effective amendment to a registration statement

Post Effective Amendment to S-8

Post Effective Amendment to S-8

Notification of removal from listing and/or registration on a national securities exchange

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Registration statement under Securities Act of 1933

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Written communication about a business combination transaction (Rule 425)

Written communication about a business combination transaction (Rule 425)

Prospectus Supplement for Primary Offering

Written communication about a business combination transaction (Rule 425)

Registration statement under Securities Act of 1933 (amendment)

Registration statement under Securities Act of 1933 (amendment)

Written communication about a business combination transaction (Rule 425)

Written communication about a business combination transaction (Rule 425)

Written communication about a business combination transaction (Rule 425)

Registration statement under Securities Act of 1933 (amendment)

Written communication about a business combination transaction (Rule 425)

Additional Information for Proxy Statement/ Votes

Additional Information for Proxy Statement/ Votes

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Additional Information for Proxy Statement/ Votes

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Definitive Proxy Statement

Definitive Proxy Statement

Definitive Proxy Statement

DIMENSIONAL FUND ADVISORS LP

BERG W ROBERT

Opto Circuits (India) LTD

Browne Noreen H

Alberstone Todd T

Andrews Ronald Asbury

Ford Alfred J

Lemvigh Kurt

MARVER DAVID L

MATYSIK MICHAEL K

Mickelson Tim

NAUMANN-ETIENNE RUEDIGER

Odell Robert W

Thompson Barbara J

Titus Ralph A

Andrews Ronald Asbury

Odell Robert W

MARVER DAVID L

Browne Noreen H

BERG W ROBERT

Letter from the SEC

No description available

No description available

No description available

No description available

No description available

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

No description available

No description available

2.01,3.02,5.02,5.03,8.01,9.01

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Letter from the SEC